Leptin and the Ob-Receptor as Anti-Obesity Target: Recent In Silico Advances in the Comprehension of the Protein-Protein Interaction and Rational Drug Design of Anti- Obesity Lead Compounds

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|1|136-145

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.1, 2014-01, pp. : 136-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in anti-obesity therapeutics

By Fong Tung M  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 243-250

Informa Healthcare

Access to resources Recommend Favorite

Anti-obesity drug development

By Bays Harold   Dujovne Carlos  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1189-1204

Informa Healthcare

Access to resources Recommend Favorite

Ghrelin as a Potential Anti-Obesity Target

By  

Current Pharmaceutical Design, Vol. 9, Iss. 17, 2003-07 ,pp. : 1383-1395

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Obesity

By  

Current Bioactive Compounds, Vol. 2, Iss. 4, 2006-12 ,pp. : 491-491

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Obesity

By  

Current Bioactive Compounds, Vol. 2, Iss. 3, 2006-09 ,pp. : 384-385

Bentham Science Publishers

Access to resources Recommend Favorite